Top Story

Adjuvant chemotherapy improves survival for men with high-risk, localized prostate cancer

May 30, 2015

Read the Perspective from Charles J. Ryan, MD

CHICAGO — The addition of docetaxel chemotherapy to standard hormone and radiation therapy reduced the risk for death in men with high-risk, localized prostate cancer, according to findings from a phase 3 study presented at the ASCO Annual Meeting.

“This is the first study that shows there is a potential survival benefit to using chemotherapy in this high-risk patient subset,” Howard M. Sandler, MD, MS, FASTRO, chair of the department of radiation oncology at Cedars-Sinai Medical Center, Los Angeles, said during a press conference. “For the right patient and the right physician there will be justification based on these results for adding adjuvant docetaxel, a relatively familiar and well-tolerated systemic chemotherapy regimen.”

Ruben A. Mesa, MD Meeting News CoveragePerspective

Pacritinib improves symptom control, reduces spleen volume in patients with myelofibrosis

May 30, 2015
CHICAGO — Pacritinib more effectively induced sustained spleen volume reduction and symptom control in patients with myelofibrosis compared with best available…
Meeting News CoveragePerspective

Ibrutinib combination confers significant benefit in relapsed CLL

May 30, 2015
CHICAGO – The addition of ibrutinib to bendamustine and rituximab conferred an 80% reduction in the risk for progression or death in patients with previously…
Saad Usmani, MD Meeting News Coverage

Daratumumab appears safe, effective in heavily pretreated multiple myeloma

May 30, 2015
CHICAGO – The monoclonal antibody daratumumab yielded durable single-agent activity in patients with heavily treated multiple myeloma, according to the results of…
Meeting News Coverage

Nivolumab yields superior OS in NSCLC compared with docetaxel

May 30, 2015
CHICAGO — Nivolumab conferred a 3-month median OS advantage in patients with non-squamous non–small cell lung cancer who progressed on platinum-based doublet…
More News Headlines »
CME CNE
Stem Cell Transplant for AAMDS

Treatment Decision-Making through the Spectrum of MDS:
Case 3 Stem Cell Transplant for MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain to…
More »
Meeting News Coverage Video
VIDEO: Updates in prostate cancer treatment options

VIDEO: Updates in prostate cancer treatment options

May 5, 2015
Robert S. DiPaola, MD, director of Rutgers Cancer Institute of New Jersey, discusses various forms of prostate cancer…
More »
CME CNE
High Risk AAMDS

Treatment Decision-Making through the Spectrum of MDS:
Case 2 High Risk MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain to…
More »
morganatic-roan